IL149754A0 - Polypeptides containing an immunogenic portion of a chlamydia antigen and pharmaceutical compositions containing the same - Google Patents

Polypeptides containing an immunogenic portion of a chlamydia antigen and pharmaceutical compositions containing the same

Info

Publication number
IL149754A0
IL149754A0 IL14975400A IL14975400A IL149754A0 IL 149754 A0 IL149754 A0 IL 149754A0 IL 14975400 A IL14975400 A IL 14975400A IL 14975400 A IL14975400 A IL 14975400A IL 149754 A0 IL149754 A0 IL 149754A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
same
immunogenic portion
chlamydia antigen
compositions containing
Prior art date
Application number
IL14975400A
Other languages
English (en)
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/556,877 external-priority patent/US6432916B1/en
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of IL149754A0 publication Critical patent/IL149754A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL14975400A 1999-12-03 2000-12-04 Polypeptides containing an immunogenic portion of a chlamydia antigen and pharmaceutical compositions containing the same IL149754A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US45468499A 1999-12-03 1999-12-03
US09/556,877 US6432916B1 (en) 1998-12-08 2000-04-19 Compounds and methods for treatment and diagnosis of chlamydial infection
US09/598,419 US6565856B1 (en) 1998-12-08 2000-06-20 Compounds and methods for treatment and diagnosis of chlamydial infection
PCT/US2000/032919 WO2001040474A2 (en) 1999-12-03 2000-12-04 Compounds and methods for treatment and diagnosis of chlamydial infection

Publications (1)

Publication Number Publication Date
IL149754A0 true IL149754A0 (en) 2002-11-10

Family

ID=27412613

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14975400A IL149754A0 (en) 1999-12-03 2000-12-04 Polypeptides containing an immunogenic portion of a chlamydia antigen and pharmaceutical compositions containing the same

Country Status (16)

Country Link
US (1) US6565856B1 (pl)
EP (1) EP1238084A2 (pl)
JP (1) JP2003515343A (pl)
KR (1) KR20020073136A (pl)
CN (1) CN1437652A (pl)
AU (1) AU1815901A (pl)
BR (1) BR0016066A (pl)
CA (1) CA2390088A1 (pl)
CZ (1) CZ20021897A3 (pl)
HU (1) HUP0203705A2 (pl)
IL (1) IL149754A0 (pl)
MX (1) MXPA02005504A (pl)
NO (1) NO20022592L (pl)
NZ (1) NZ518917A (pl)
PL (1) PL355977A1 (pl)
WO (1) WO2001040474A2 (pl)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030219453A1 (en) * 1998-03-19 2003-11-27 Smithkline Beecham Biologicals, Sa Vaccines
US7459524B1 (en) * 1997-10-02 2008-12-02 Emergent Product Development Gaithersburg Inc. Chlamydia protein, sequence and uses thereof
EP1105489A1 (en) 1998-08-20 2001-06-13 Aventis Pasteur Limited Nucleic acid molecules encoding pomp91a protein of chlamydia
WO2000011181A1 (en) 1998-08-20 2000-03-02 Connaught Laboratories Limited NUCLEIC ACID MOLECULES ENCODING INCLUSION MEMBRANE PROTEIN C OF $i(CHLAMYDIA)
US6686339B1 (en) 1998-08-20 2004-02-03 Aventis Pasteur Limited Nucleic acid molecules encoding inclusion membrane protein C of Chlamydia
US6649370B1 (en) 1998-10-28 2003-11-18 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
US6607730B1 (en) 1998-11-02 2003-08-19 Aventis Pasteur Limited/Aventis Pasteur Limitee Chlamydia antigens and corresponding DNA fragments and uses thereof
CA2353107A1 (en) 1998-12-01 2000-06-08 Andrew D. Murdin Chlamydia antigens and corresponding dna fragments and uses thereof
US20080213264A1 (en) * 1998-12-08 2008-09-04 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
JP2002531129A (ja) 1998-12-08 2002-09-24 コリクサ コーポレイション クラミジア感染の処置および診断のための化合物および方法
US6565856B1 (en) 1998-12-08 2003-05-20 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US20020061848A1 (en) * 2000-07-20 2002-05-23 Ajay Bhatia Compounds and methods for treatment and diagnosis of chlamydial infection
US6555115B1 (en) 1998-12-08 2003-04-29 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
GB9828000D0 (en) 1998-12-18 1999-02-10 Chiron Spa Antigens
US7297341B1 (en) 1998-12-23 2007-11-20 Sanofi Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
JP2002541766A (ja) 1998-12-28 2002-12-10 アベンティス、パストゥール、リミテッド クラミジア抗原および対応するｄｎａ断片ならびにその使用
US6808713B1 (en) 1998-12-28 2004-10-26 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
GB9902555D0 (en) 1999-02-05 1999-03-24 Neutec Pharma Plc Medicament
MXPA01009256A (es) 1999-03-12 2003-07-14 Aventis Pasteur Antigenos de chlamydia y fragmentos de acido desoxirribonucleico correspondientes y usos de los mismos.
DE60036698T2 (de) 1999-05-03 2008-07-24 Sanofi Pasteur Ltd., Toronto Chlamydia-antigene und entsprechende dna-fragmente und deren verwendungen
NZ517952A (en) 1999-09-20 2004-01-30 Aventis Pasteur Chlamydia antigens and corresponding DNA fragments and uses thereof
US6632663B1 (en) 1999-09-22 2003-10-14 Aventis Pasteur Limited DNA immunization against chlamydia infection
EP1240331B1 (en) 1999-12-22 2010-04-07 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
WO2001081379A2 (en) * 2000-04-21 2001-11-01 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US6919187B2 (en) * 2000-04-21 2005-07-19 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
AU2001258105A1 (en) 2000-05-08 2001-11-20 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
JP2004502415A (ja) 2000-07-03 2004-01-29 カイロン　エセ．ピー．アー． Ｃｈｌａｍｙｄｉａｐｎｅｕｍｏｎｉａｅに対する免疫化
US7537772B1 (en) * 2000-10-02 2009-05-26 Emergent Product Development Gaithersburg Inc. Chlamydia protein, gene sequence and the uses thereof
US7731980B2 (en) * 2000-10-02 2010-06-08 Emergent Product Development Gaithersburg Inc. Chlamydia PMP proteins, gene sequences and uses thereof
GB0103169D0 (en) * 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition
US6925469B2 (en) * 2001-03-30 2005-08-02 Intertainer, Inc. Digital entertainment service platform
RU2331435C2 (ru) 2001-12-12 2008-08-20 Чирон Срл. Иммунизация против chlamydia trachomatis
GB0203403D0 (en) 2002-02-13 2002-04-03 Chiron Spa Chlamydia cytotoxic-T cell epitopes
JP2007512006A (ja) * 2003-11-10 2007-05-17 ザ ユーエービー リサーチ ファウンデーション 細菌輸送およびｃｎｓ侵襲を低減させるための組成物およびこの組成物を使用する方法
WO2006104890A2 (en) 2005-03-31 2006-10-05 Glaxosmithkline Biologicals Sa Vaccines against chlamydial infection
US8541007B2 (en) 2005-03-31 2013-09-24 Glaxosmithkline Biologicals S.A. Vaccines against chlamydial infection
US9259463B2 (en) * 2006-01-16 2016-02-16 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Chlamydia vaccine
WO2008022299A1 (en) * 2006-08-17 2008-02-21 The Uab Research Foundation Diagnosing pneumococcal pneumonia
NL1033345C1 (nl) 2007-02-06 2008-08-07 Vereniging Voor Christelijk Ho Werkwijze voor het detecteren van Chlamydia trachomatis en een kit daarvoor.
EP2152303A4 (en) * 2007-05-01 2011-10-05 Univ Texas CHLAMYDIENE ANTIGENES AS REAGENTS FOR THE DIAGNOSIS AND TREATMENT OF CHLAMYDIEN INFECTION AND DISEASE
US20100260791A1 (en) * 2007-08-03 2010-10-14 President And Fellows Of Harvard Chlamydia antigens
US7892567B2 (en) * 2007-10-01 2011-02-22 Board Of Regents, The University Of Texas System Methods and compositions for immunization against chlamydial infection and disease
CA2744739A1 (en) * 2007-12-03 2009-06-11 President And Fellows Of Harvard College Chlamydia antigens
JP4798125B2 (ja) * 2007-12-13 2011-10-19 株式会社デンソー 照度センサ
AU2009302821A1 (en) 2008-10-09 2010-04-15 Board Of Regents, University Of Texas System Methods and compositions for chlamydial antigens for diagnosis and treatment of chlamydial infection and disease
US8204859B2 (en) * 2008-12-10 2012-06-19 Commvault Systems, Inc. Systems and methods for managing replicated database data
US8568732B2 (en) 2009-03-06 2013-10-29 Novartis Ag Chlamydia antigens
WO2011118496A1 (ja) 2010-03-23 2011-09-29 和光純薬工業株式会社 クラミジア・トラコマティス検出用プライマー及びプローブ、並びにこれを用いたクラミジア・トラコマティスの検出方法
CN121513216A (zh) 2018-03-08 2026-02-13 应用分子转运公司 用于经口递送的毒素衍生的递送构建体
WO2020096695A1 (en) * 2018-11-07 2020-05-14 Applied Molecular Transport Inc. Cholix-derived carriers for oral delivery of heterologous payload
MX2022001975A (es) 2019-08-16 2022-03-11 Applied Molecular Transport Inc Composiciones, formulaciones y produccion y purificacion de interleucinas.
CN112779248B (zh) * 2021-02-04 2022-12-02 杭州遂曾生物技术有限公司 一种沙眼衣原体一体化核酸检测卡盒

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4118469A (en) 1976-04-27 1978-10-03 Research Corporation Antigen for trachoma lymphogranuloma venereum (LGV) and non-gonococcal urethritis (NGU)
US4497863A (en) 1984-03-07 1985-02-05 Milliken Research Corporation Laminated weft insertion fabric
US5166053A (en) 1990-02-23 1992-11-24 Miles Inc. Specimen adequacy control for chlamydia assays
JP3018553B2 (ja) 1990-05-08 2000-03-13 日立化成工業株式会社 クラミジア・トラコマティス抗体測定方法及びクラミジア・トラコマティス感染症診断用製剤
US5549978A (en) 1992-10-30 1996-08-27 Kabushiki Kaisha Toshiba Magnetoresistance effect element
DE69535914D1 (de) 1994-09-20 2009-03-26 Hitachi Chemical Co Ltd Polynukleotide die einen antigenes polypeptid aus chlamydia pneumoniae kodieren
GB9516293D0 (en) 1995-08-09 1995-10-11 Immunova Ltee Novel peptides and their use as vaccines
ATE312920T1 (de) 1996-07-12 2005-12-15 Dna immunisierung gegen chlamydia infektion
US6464979B1 (en) 1996-09-12 2002-10-15 Aventis Pasteur Limited Chlamydial vaccines and methods of preparation thereof
JP2002536958A (ja) 1997-11-21 2002-11-05 ジェンセット Ｃｈｌａｍｙｄｉａｐｎｅｕｍｏｎｉａｅゲノム配列およびポリペプチド、それらのフラグメント、ならびに特に感染症の診断、予防および治療のためのそれらの使用
EP2218731A1 (en) 1997-11-28 2010-08-18 Merck Serono Biodevelopment Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
PL202844B1 (pl) 1998-04-07 2009-07-31 Corixa Corp Immunogeniczny polipeptyd, polinukleotyd, polipeptyd, kompozycja farmaceutyczna, wektor ekspresji, kompozycja szczepionki, polipeptyd do stosowania w leczeniu lub zapobieganiu infekcjom Mycobacterium tuberculosis, polinukleotyd do stosowania w leczeniu lub zapobieganiu infekcjom Mycobacterium tuberculosis i sposób wytwarzania polipeptydu
US6565856B1 (en) 1998-12-08 2003-05-20 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
JP2002531129A (ja) 1998-12-08 2002-09-24 コリクサ コーポレイション クラミジア感染の処置および診断のための化合物および方法

Also Published As

Publication number Publication date
NO20022592L (no) 2002-07-19
CZ20021897A3 (cs) 2003-02-12
CA2390088A1 (en) 2001-06-07
HUP0203705A2 (hu) 2003-03-28
MXPA02005504A (es) 2002-10-31
BR0016066A (pt) 2003-06-10
NZ518917A (en) 2004-06-25
WO2001040474A2 (en) 2001-06-07
JP2003515343A (ja) 2003-05-07
KR20020073136A (ko) 2002-09-19
EP1238084A2 (en) 2002-09-11
AU1815901A (en) 2001-06-12
NO20022592D0 (no) 2002-05-31
WO2001040474A3 (en) 2002-03-07
US6565856B1 (en) 2003-05-20
PL355977A1 (pl) 2004-05-31
CN1437652A (zh) 2003-08-20

Similar Documents

Publication Publication Date Title
IL149754A0 (en) Polypeptides containing an immunogenic portion of a chlamydia antigen and pharmaceutical compositions containing the same
IL142216A0 (en) A polypeptide containing an immunogenic portion of a native wti and pharmaceutical compositions containing the same
IL150224A0 (en) Lipopeptides and pharmaceutical compositions containing the same
EG24044A (en) pharmaceutical formulation of omeprazole
IL150223A0 (en) Lipopeptides and pharmaceutical compositions containing the same
IL191904A0 (en) Pharmaceutical and compositions containing a?? fragments
PL331531A1 (en) Pharmaceutical aerosol compositions
IL146230A0 (en) 3α-HYDROXY-3β-METHOXYMETHYL-SUBSTITUTED STEROIDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
IL131201A0 (en) Pharmaceutical formulations comprising amoxocyllin and clavulanate
IL136251A0 (en) Soft pellet drug composition and methods for the preparation thereof
IL131319A0 (en) 3-Piperidyl-4- oxoquinazoline derivatives and medicinal compositions containing the same
HUP0100149A3 (en) Antipicornaviral peptide derivatives pharmaceutical compositions comprising thereof and their use
HUP0001309A3 (en) 1-phenyl-4-benzylpiperazines and pharmaceutical compositions containing them
IL133097A0 (en) Aroyl-piperazine derivatives pharmaceutical compositions containing the same and the use thereof
HUP0100470A3 (en) Oxazolidinone derivatives and pharmaceutical compositions containing them
ZA983849B (en) Pharmaceutical compositions of tizoxanide and nitazoxanide.
IL145733A0 (en) A polpyeptide containing an immunogenic portion of a breast protein and pharmaceutical compositions containing the same
HUP0101701A3 (en) Substituted betha-alanines and pharmaceutical compositions comprising them
CZ2000522A3 (cs) Farmaceutický prostředek na bázi piperidinalkanolového antihistaminika a použití
HUP0003330A3 (en) Pharmaceutical compositions containing tizoxanide and nitazoxanide
HUP0000460A3 (en) Imidazopyridazines and pharmaceutical compositions thereof
ZA9811470B (en) Pharmaceutical compositions based on dalfopristine and on quinupristine and their preparation
IL125262A0 (en) Synthetic peptides and pharmaceutical compositions comprising them
IL136045A0 (en) Pyridylpyrrole derivatives and pharmaceutical compositions containing the same
IL131266A0 (en) Peptides and pharmaceutical compositions comprising same